These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17403202)

  • 1. A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.
    Matsuo O; Lijnen HR; Ueshima S; Kojima S; Smyth SS
    J Thromb Haemost; 2007 Apr; 5(4):680-9. PubMed ID: 17403202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to murine coagulation factor structure, function, assays, and genetic alterations.
    Emeis JJ; Jirouskova M; Muchitsch EM; Shet AS; Smyth SS; Johnson GJ
    J Thromb Haemost; 2007 Apr; 5(4):670-9. PubMed ID: 17403201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent].
    Rueda F; Félez J
    Sangre (Barc); 1984; 29(4-A):429-48. PubMed ID: 6390755
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis: molecular mechanism and pathophysiological aspects.
    Lijnen HR
    Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system.
    Carmeliet P; Collen D
    Thromb Haemost; 1995 Jul; 74(1):429-36. PubMed ID: 8578500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene targeting in hemostasis. plasminogen.
    Ploplis VA
    Front Biosci; 2001 Mar; 6():D555-69. PubMed ID: 11229877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin-specific thrombolytic agents.
    Collen D
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():19-23. PubMed ID: 3142407
    [No Abstract]   [Full Text] [Related]  

  • 13. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelium and endogenous fibrinolysis].
    Nordt TK; Bode C
    Z Kardiol; 2000 Mar; 89(3):219-26. PubMed ID: 10798278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place and role of tissue plasminogen activator in the fibrinolysis process].
    Wilczyńska M; Cierniewski C
    Postepy Hig Med Dosw; 1984; 38(4):481-97. PubMed ID: 6399108
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE; Santoro SA; Sobel BE; Jaffe AS
    Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of the plasminogen/plasmin system.
    Lijnen HR
    Int J Clin Lab Res; 1996; 26(1):1-6. PubMed ID: 8739849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural antithrombotic mechanisms. II. The fibrinolytic system].
    Mamont B
    Kardiol Pol; 1988; 31(2):117-22. PubMed ID: 3045395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.